The prognostic role of level of involved regional lymph node in patients with stage Ⅱ extranodal nasal-type NK/T-cell lymphoma of the upper aerodigestive tract
Department of Radiation Oncology (Wu RY,Qi SN,Chen B,Jin J,Wang SL,Liu YP,Song YW,Tang Y,Tang Y,Li N,Lu NN,Ren H,Fang H,Yang Y,Wang WH,Li YX),Imaging Diagnosis (Liu K,Ouyang H),National Cancer Center/Cancer Hospital,Chinese Academy of Medical Sciences,Peking Union Medical College,Beijing 100021,China
Abstract： Objective This study aimed to evaluate the prognostic value of regional lymph node spread in patients with stage Ⅱ nasal-type NK/T-cell lymphoma of the upper aerodigestive tract (UADT-NKTCL). Methods From 1987 to 2013,a total of 97 patients with newly-diagnosed stage Ⅱ UADT-NKTCL were retrospectively reviewed. Primary tumors were located in the nasal cavity (n=52) or extranasal UADT sites (n=45).The majority of patients were treated with primary radiotherapy. Sixty-five patients were treated with combined modality therapy (CMT),and 32 patients were treated with radiotherapy alone (n=27) or chemotherapy alone (n=5).The Kaplan-Meier method was used to calculate the survival rate, and the log-rank test was used for survival difference analysis and monovariate prognostic analysis. The Cox regression model was used to multivariate prognostic analysis. Results The 5-year overall survival (OS) and progression-free survival (PFS) rates for all stage Ⅱ patients were 57% and 49%,respectively. The presence of a lower neck lymph node (defined as extension below the caudal border of the cricoid cartilage) was significantly associated with poor outcomes on univariate analysis and maintained significance on multivariate analysis. The median survival for patients with lower neck lymph node was 19.3 months and the 2-,5-years OS rates were 28% and 11%(P=0.000).For stage Ⅱ patients,CMT significantly improved survival. The 5-year OS and PFS rates were 64% and 52% for CMT,compared with 40.4%(P=0.006) and 42% for single modality therapy (P=0.088). Conclusion The level of regional lymph node is a powerful prognostic factor for stage Ⅱ UADT-NKTCL.The involvement of low neck lymph node is significantly associated with poorer survival outcomes.
Wu Runye,Qi Shunang,Chen Bo et al. The prognostic role of level of involved regional lymph node in patients with stage Ⅱ extranodal nasal-type NK/T-cell lymphoma of the upper aerodigestive tract[J]. Chinese Journal of Radiation Oncology, 2017, 26(6): 636-640.
[1] Li YX,Yao B,Jin J,et al. Radiotherapy as primary treatment for stage ⅠE and ⅡE nasal natural killer/T-cell lymphoma[J].J Clin Oncol,2006,24(1):181-189. [2] Vose J,Armitage J,Weisenburger D.International peripheral T-cell and natural killer/T-cell lymphoma study:pathology findings and clinical outcomes[J].J Clin Oncol,2008,26(25):4124-4130.DOI:10.1200/JCO.2008.16.4558. [3] Au WY,Weisenburger DD,Intragumtornchai T,et al. Clinical differences between nasal and extranasal natural killer/T-cell lymphoma:a study of 136 cases from the International Peripheral T-Cell Lymphoma Project[J].Blood,2009,113(17):3931-3937. [4] 吴润叶,李晔雄,王维虎,等.原发韦氏环弥漫性大B细胞与结外鼻型NK/T细胞淋巴瘤的临床特征和预后比较[J].中华放射肿瘤学杂志,2012,21(3):231-235.DOI:10.3760/cma.j.issn.1004-4221.2012.03.011. Wu RY,Li YX,Wang WH,et al. Comparison of clinical features and prognosis of diffuse large B cell and extranodal nasal type NK/T cell lymphoma[J].Chin J Radiat Oncol,2012,21(3):231-235.DOI::10.3760/cma.j.issn.1004-4221.2012.03.011. [5] Fang H,Jin J,Wang WH,et al. Prognostic factors and treatment outcomes for patients with stage Ⅱ extranodal nasal-type natural killer/T-cell lymphoma of the upper aerodigestive tract[J].Leuk Lymphoma,2014,55(8):1832-1837.DOI:10.3109/10428194.2013.852668. [6] Yang Y,Zhu Y,Cao JZ,et al. Risk-adapted therapy for early-stage extranodal nasal-type NK/T-cell lymphoma:analysis from a multicenter study[J].Blood,2015,126(12):1424-1432.DOI:10.1182/blood-2015-04-639336. [7] Lee J,Suh C,Park YH,et al. Extranodal natural killer T-cell lymphoma,nasal-type:a prognostic model from a retrospective multicenter study[J].J Clin Oncol,2006,24(4):612-618. [8] Kim SJ,Yoon DH,Jaccard A,et al. A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment:a multicenter,retrospective analysis[J].Lancet Oncol,2016,17(3):389-400.DOI:10.1016/S1470-2045(15)00533-1. [9] Cheson BD,Horning SJ,Coiffier B,et al. Report of an international workshop to standardize response criteria for non-Hodgkin’s lymphomas[J].J Clin Oncol,1999,17(4):1244-1253. [10] King AD,Lei KI,Ahuja AT.MRI of neck nodes in non-Hodgkin′s lymphoma of the head and neck[J].Br J Radiol,2004,77(914):111-115. [11] Gregoire V,Levendag P,Ang KK,et al. CT-based delineation of lymph node levels and related CTVs in the node-negative neck:DAHANCA,EORTC,GORTEC,NCIC,RTOG consensus guidelines[J].Radiother Oncol,2003,69(3):227-236. [12] Wu RY,Liu K,Wang WH,et al. Patterns of primary tumor invasion and regional lymph node spread based on magnetic resonance imaging in early-stage nasal NK/T-cell lymphoma:implications for clinical target volume definition and prognostic significance[J].Int J Radiat Oncol Biol Phys,2017,97(1):50-59.DOI:10.1016/j.ijrobp.2016.09.013. [13] Lin JC,Wang WY,Chen KY,et al. Quantification of plasma epstein-barr virus DNA in patients with advanced nasopharyngeal carcinoma[J].N Engl J Med,2004,350(24):2461-2470. [14] Wang ZY,Liu QF,Wang H,et al. Clinical implications of plasma epstein-barr virus DNA in early-stage extranodal nasal-type NK/T-cell lymphoma patients receiving primary radiotherapy[J].Blood,2012,120(10):2003-2010. [15] Pan JJ,Ng WT,Zong JF,et al. Prognostic nomogram for refining the prognostication of the proposed 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy[J].Cancer,2016,122(21):3307-3315.DOI:10.1002/cncr.30198. [16] Yan Z,Huang HQ,Wang XX,et al. A TNM staging system for nasal NK/T-cell lymphoma[J/OL].PLoS One,2015,10(6):e0130984.DOI:10.1371/journal.pone.0130984. [17] Rohatiner A,d′Amore F,Coiffier B,et al. Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma[J].Ann Oncol,1994,5(5):397-400. [18] Kim YH,Willemze R,Pimpinelli N,et al. TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and sezary syndrome:a proposal of the international society for cutaneous lymphomas (ISCL) and the cutaneous lymphoma task force of the European organization of research and treatment of cancer (EORTC)[J].Blood,2007,110(2):479-84. [19] Li YX,Fang H,Liu QF,et al. Clinical features and treatment outcome of nasal-type NK/T-cell lymphoma of Waldeyer ring[J].Blood,2008,112(8):3057-3064.DOI:10.1182/blood-2008-05-160176.10. [20] Moon SH,Cho SK,Kim WS,et al. The Role of 18F-FDG PET/CT for initial staging of nasal type natural killer/T-cell lymphoma:a comparison with conventional staging methods[J].J Nucl Med,2013,54(7):1039-1044.10.2967/jnumed.112.113399.
2017, Vol. 26 
